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ABSTRACT 
 
SMOOTH MUSCLE CELL ORGANIZATION IN THE STEM REGION OF THE GRACILIS 
COLLATERAL CIRCULATION 
 
Amanda Krall 
 
Many patients who suffer from the ischemic Peripheral Arterial Occlusive Disease 
(PAOD) experience intermittent claudication, which can be attributed to impaired 
vasodilation. Collateral vessels are the primary site of resistance to blood flow 
downstream; therefore maximizing vasodilation in collaterals is crucial for efficient 
circulation. Collaterals function as natural bypasses around the occluded arteries 
and the increase in flow into these vessels causes them to outwardly remodel into 
conduit vessels. However, functional vasodilation in the stem region of collateral 
vessels is impaired at day 7 following femoral ligation, which can be attributed to 
smooth muscle cell malfunction. However, the increase in vessel diameter in 
outwardly remodeled collaterals is not due to cell proliferation. One possible 
explanation for the diameter increase in the stem region of the collateral is that the 
vascular smooth muscle cells undergo mechanoadaptation to acclimate to the 
increase in blood flow and fluid shear stress. To test this hypothesis, outward 
remodeling was induced in the gracilis collateral stem via femoral artery ligation. At 
day 7 following surgery, maximal vasodilation in the profunda femoris artery 
(collateral stem) was evaluated before perfusion fixation. The profunda was then 
resected and immunostained before measuring smooth muscle cell length and 
overlap using confocal microscopy. Average SMC overlap was significantly less in 
the collateral artery, 43 ± 1 μm versus 51 ± 2 μm in the control artery. Also, average 
SMC length was significantly longer in the collateral artery 249 ± 13 μm versus 205 
± 10 μm in the control. These results indicate that mechanoadaptation occurred in 
the collateral stem and its correlation to impaired vasodilation suggests that the 
reorientation and remodeling associated with mechanoadaptation may play a causal 
role in vessel impairment. Further studies need to be performed to determine if 
mechanoadaptation causes impaired vasodilation for patients with PAOD. 
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INTRODUCTION 
Peripheral Arterial Occlusive Disease 
 
 Peripheral Arterial Occlusive Disease (PAOD) affects 12 million Americans, 
and disease prevalence increases with age [1].  PAOD is characterized by the 
narrowing of arteries due to atherosclerotic plaque accumulation in the lower 
extremities and is a strong predictor for coronary heart disease. These obstructions 
can lead to ischemia, or an insufficient blood supply. Subsequently, there is an 
inadequate amount of oxygen and glucose required for metabolic function in the 
peripheral tissues [2].  
 
Figure 1: Peripheral Arterial Occlusive Disease. Narrowed arteries and reduced 
blood flow due to plaque buildup that causes PAOD [3]. 
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Intermittent claudication, which is pain caused by deficient blood flow 
during exercise, is the result of ischemia and is the primary symptom of patients 
diagnosed with PAOD. For these individuals, pain occurs during increased activity 
and is alleviated during rest; however, if left untreated, the disease can progress to 
Critical Limb Ischemia (CLI), a very severe form of PAOD characterized by chronic 
ischemic pain at rest [4]. Risk factors for PAOD include age, obesity, cigarette 
smoking, diabetes mellitus, physical inactivity, high blood pressure, and high 
cholesterol. Patients who have PAOD experience a lower the quality of life because 
they must constantly endure uncomfortable physical pain during daily activity [2]. 
Current Treatment Methods for Patients with PAOD  
The effectiveness of current treatment options for PAOD is limited. The first 
step following diagnosis is lifestyle changes, such as increasing exercise and eating a 
balanced, healthy diet. Other treatment options include medications that prevent 
blood clots, lower cholesterol, or relieve symptoms to improve claudication [5]. 
Often these drugs are palliative, and alleviate the primary symptoms but do not 
treat the underlying issue of impaired vasodilation. In more severe cases, 
angioplasty or bypass surgery may be performed. Angioplasty is a minimally 
invasive procedure that involves placing a balloon catheter at the blockage site and 
inflating it to widen the artery. In many cases a stent is deployed in the artery to 
ensure that the vessel remains patent. During this procedure, the stent is mounted 
onto the balloon and when the balloon expands, the stent is compressed against the 
arterial wall. The balloon is then deflated and removed while the stent remains in its 
position (Figure 2). Stenting generally provides immediate relief; however, the 
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vessel can undergo restenosis, or the reduction in the lumen diameter following 
stent intervention [6]. Bypass surgery is performed to circumvent an occlusion by 
surgically anastomosing a vein graft proximal and distal to the site of occlusion, as 
an alternative route for blood flow around the blocked artery. As with any surgical 
procedure there are risks associated with bypass surgery and eventually graft 
occlusion can occur, which causes a recurrence of ischemia  [7].  
 
Figure 2: Angioplasty and Stent Deployment. A balloon catheter is guided to the 
blockage site and inflated to widen the artery. A stent is left behind at the blockage 
site to keep the affected vessel open [8]. 
 
Due to the limitations of the current intervention methods, an alternative 
therapy is desired. Establishing a better understanding of the body’s natural 
physiologic response to an arterial occlusion may be beneficial in developing an 
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effective treatment for patients with PAOD. When an arterial occlusion restricts 
blood flow, blood is redirected down alternative pathways via collateral vessels, 
pre-existing arterial-arterial connections, which can act as natural bypass routes 
around occlusions. The pressure is lowered downstream of an occlusion, which 
increases blood flow and pressure in the collateral network. The increased blood 
flow increases the fluid shear stress along the wall of collateral vessels and 
stimulates arteriogenesis, the outward remodeling of collateral vessels [9].  
Arteriogenesis in Collaterals 
Arteriogenesis begins when the endothelial cells that line the luminal surface 
in the collateral vessel are activated in response to the increase in fluid shear stress. 
The endothelial cells display adhesion proteins and express monocyte 
chemoattractant protein-1 (MCP-1) on their surface to recruit monocytes to adhere 
to the endothelium. The monocytes extravasate and become macrophages that 
secrete matrix-metalloproteinases (MMPs), which degrade the matrix to allow the 
collateral to be remodeled [10]. Concomitantly, the endothelial cells secrete vascular 
endothelial growth factor (VEGF) and tumor necrosis factor-α (TNF-α) to cause 
endothelial cell and vascular smooth muscle cell (SMCs) proliferation, respectively 
[11]. This process enlarges the lumen diameter until the shear stress is normalized.  
Arteriogenesis is most often described in the mid-zone of the collateral 
circuit, however the SMC proliferation that is characteristic of arteriogenesis is 
absent from the stem region of the collateral circuit, despite an increase in resting 
diameter that is suggestive of outward remodeling. The increased resting diameter 
of the stem region in the absence of SMC proliferation may be explained by SMC 
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mechanoadaptation, the rearrangement of SMCs through changing cell length and 
cell overlap without proliferation to chronically resize the lumen diameter.  
 
 
Figure 3: Arteriogenesis. Progression of arteriogenesis, the outward remodeling of 
collateral vessels, from normal blood flow (left) to altered blood flow due to 
occlusion (right) [12]. 
 
Impaired Vasodilation 
 
Impaired vasodilation, which is observed in patients with PAOD, is a possible 
explanation for intermittent claudication because sufficient vasodilation is 
imperative for supplying adequate blood flow and nutrients to meet tissue 
metabolic demand, especially during periods of physical exertion [13]. It is also 
known that during muscle contraction arterioles vasodilate to increase blood flow 
to tissues [14]. If vasodilation was impaired this could result in inadequate nutrient 
delivery and thus pain to the extremities. Impaired vasodilation is observed in 
patients with PAOD, therefore it is useful to further study this phenomenon [15].  
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It was previously hypothesized that SMC proliferation during arteriogenesis 
was the cause of impaired vasodilation. During the outward remodeling process, 
SMCs change phenotype from contractile to synthetic since the synthetic phenotype 
is more proliferative. This results in an increase in number of SMC cells with non-
contractile function, which would enlarge the diameter, but may impair the vessel’s 
reactivity [16]. However, proliferation was not observed in the collateral stem and 
could not be a cause of impairment, therefore SMC mechanoadaptation has been 
considered. Changing of SMC length and overlap causes substantial structural 
changes to the cell components, which may have debilitating effects on cell 
contraction and relaxation. 
Previous Work  
 
Resting diameter of the profunda femoris artery (stem to the gracilis 
collateral circuit) is increased at day-7 following femoral artery occlusion, however 
the percent change from resting to maximally dilated diameter is reduced, which 
indicated a decreased dynamic range in the vessel. There is also an increase in blood 
flow in the profunda femoris artery at day-7. Also at day 7 in the occluded hindlimb, 
smooth muscle-dependent vasodilation is significantly impaired in the profunda 
femoris artery [17]. Surprisingly the proliferation of SMCs did not occur in the 
profunda femoris artery following femoral ligation and there was no significant 
difference in the number of SMCs between the ligated and non-ligated hindlimbs, 
indicating that the increase in vessel diameter was not due to cell proliferation. This 
suggests that the cause of the impairment of the collateral stem needs to be studied 
further [16].  
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Given the absence of SMC proliferation, mechanoadaptation has been further 
investigated.  SMCs in rat arterioles undergo mechanoadaptation in response to 
prolonged exposure to the vasoconstrictor norepinephrine (NE). The vessels 
showed a decrease in vessel diameter as well as an increase in SMC overlap, 
indicating that the SMCs mechanically reoriented themselves to acclimate to the 
change in their environment and cause remodeling of the vascular wall (Figure 4) 
[18]. Mechanoadaptation can work in the opposite direction and may cause an 
increase in lumen diameter through an increase in SMC length and a decrease in 
SMC overlap.  
 
Figure 4:  Mechanoadaptation in Rat Arterioles. Study investigated by Martinez-
Lemus et al. showed an increase in SMC overlap when rat arterioles were exposed to 
vasoconstrictors for extended periods of time [18]. 
 
Specific Aims 
 
Patients with PAOD experience intermittent claudication, which may be 
explained by impaired vasodilation of the collateral network. Impaired vasodilation 
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cannot be explained by SMC proliferation; therefore SMC mechanoadaptation and its 
role in vessel impairment must be further studied. The objectives of this study were 
to: 
1. Test the hypothesis that the collateral stem undergoes outward 
remodeling by comparing resting diameter to papaverine and SNP 
induced maximal vasodilation 
2. Test the hypothesis that the outward remodeling that occurs can be 
explained by smooth muscle cell mechanoadaptation 
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MATERIALS AND METHODS 
 
Animal Husbandry 
 
Male C57BL/6 mice were used for all procedures according to experimental 
protocols that were approved by the Institutional Animal Care and Use Committee 
(IACUC) of California Polytechnic State University. The mice were housed in the Cal 
Poly vivarium in micro-isolator cages within a temperature controlled room on a 12 
hour light-dark cycle. Mice were monitored daily and were provided with 
enrichment, and feed and water ad libitum. 
Femoral Artery Ligation Surgery 
 
An arterial occlusion was simulated in the mouse hindlimb via femoral artery 
ligation. Prior to surgery, the instruments and materials were sterilized in an 
autoclave and the surgery bench was disinfected with 70% isopropyl alcohol. Mice 
were anesthetized with 1-3% isoflourane gas in oxygen at a flow rate between 0.8-
1.2 l·min-1. The hair on the anterior hindlimb was depilated and the underlying skin 
disinfected with Nolvasan. The animal was then placed supine on a heated surgical stage 
and a rectal probe thermometer was inserted to maintain internal body temperature at 
35oC.  
 An incision was made in the medial aspect of the hindlimb and extended 
proximally to the abdominal wall. Phosphate buffered saline (PBS) was applied to the 
surgical site throughout the procedure to prevent tissue desiccation. The connective tissue 
was blunt dissected and the epigastric fat pad was repositioned medially using a retractor 
to expose the ligation site. At the ligation site, S&T forceps were used to separate the 
nerve from the femoral artery-vein pair and #5/45 Dumont forceps were used to separate 
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the vein from the artery. The femoral artery was ligated distal to the epigastric branch and 
proximal to the popliteal branch (Figure 5) using polypropylene suture. The contralateral 
hindlimb was un-operated for control. 
 
 
Figure 5:  Femoral Ligation Procedure and Blood Flow Path. A) Normal blood 
flow in a hindlimb. B) Site of ligation (X) and consequent blood flow pathway 
through gracilis collateral network. 
 
Intravital Microscopy 
 
Intravital microscopy was used to assess vasodilation of the collateral stem artery 
7 days following femoral artery ligation. Mice were anesthetized and prepared as 
discussed in the previous section. An incision was made in the hindlimb and the 
epigastric fat pad was resected using a heat cautery. Plastic wrap was placed over the 
exposed tissue to prevent desiccation and the profunda femoris artery was given 30 
minutes to reach a stable resting diameter.  
A B 
Site of Ligation 
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Figure 6:  Intravital Microscopy Preparation. A) Experimental set-up during day-
7 procedure. B) Exposed hindlimb on mouse, images of the profunda femoris were 
taken with an intravital microscope. 
 
An intravital microscope (Olympus BXFM) with a 5x objective and QCapture 
Imaging software was used to capture images of the profunda femoris artery after the 
initial 30 min equilibration period at rest, and following maximal vasodilation (Figure 6). 
Next, vasodilators, sodium nitroprusside (SNP, 10-3) and papaverine (10-2), were applied 
to the profunda femoris artery and left to maximally dilate the artery for 5 minutes before 
another set of images was taken on both the ligated and control hindlimbs.  
Sample Fixation and Processing 
 
After intravital imaging, tissues of interest were perfusion fixed. Briefly, a 
catheter was inserted into the left ventricle through a thoracotomy, and the 
cardiovascular system was perfused with 10mL PBS, 5mL 4% paraformaldehyde 
(PFA), and 10mL PBS using a syringe pump at 4 ml⋅min-1 to maintain the 
cylindrical, in situ geometry of the profunda femoris artery. During the perfusion, 
A B 
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SNP and papaverine were periodically superfused to both hindlimbs to ensure the 
profunda femoris retained maximum diameter during perfusion fixation.  
Following perfusion fixation, the gracilis muscle and profunda femoris artery 
were resected and post-fixed in 4% PFA overnight 4oC before rinsing with PBS and 
stored at 4oC prior to staining.  
An antibody solution was prepared containing 1:200 1A4 clone (alpha-smooth 
muscle actin, Cy3 conjugate) in 0.1% saponin (in PBS) and 2% BSA, Bovine Serum 
Albumin (in PBS). Samples were removed from storage and placed into individual wells 
of a culture plate with 0.3mL of antibody solution and incubated for 7 days at 4oC. After 
incubation, the samples were washed in 0.1% saponin in PBS and covered with foil for 
20 minutes; this process was repeated 3 times. The samples were then placed in plain 
PBS for 30 minutes before preparing for depression slide mounting. One to two droplets 
of 50/50 PBS and Glycerol were placed onto each depression slide using a transfer 
pipette and each sample was placed onto a slide, covered with cover glass, sealed with 
clear nail polish to prevent tissue desiccation, and stored at 4oC covered in foil until 
imaging.  
Confocal Microscopy 
 
Images of the profunda femoris artery were captured with a confocal 
microscope at 40x oil immersion objective using Fluoview Viewer (FV10-ASW 4.1) 
software using the Texas Red filter for light emission. The profunda artery was 
imaged at the collateral stem, just proximal to the collateral branch and light power 
was adjusted individually per sample to optimize brightness and SMC clarity as well 
as minimize light saturation. A z-stack with 1μm slices was captured for 
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approximately half the circumference of each artery setting the anterior portion of 
the artery as the top of the z-stack and extending towards the posterior side. See 
APPENDIX D. 
Image Analysis 
 
ImageJ was used to measure vessel diameter at rest and at maximum dilation 
from the intravital images. ImageJ was also used to merge the z-stacks of the 
profunda femoris into 3-D reconstructions to then create a 2-D image, and from 
these images, average smooth muscle cell overlap between the individual cells could 
be measured. SMC overlap was calculated by measuring all of the observable 
overlaps between cells to compute an average; the average length of the SMCs was 
also measured from these images.  
Several considerations were made for measuring SMC length including 
attempting to rotate the 3-D reconstruction of the vessel to measure the length of 
each cell individually, ultimately however, a formula from previous studies was 
chosen to calculate the average smooth muscle cell length using a 2-D image view. 
To calculate average SMC length in a single viewing plane several assumptions must 
be made [19]: 
 
1. The vessels are fully dilated and are cylindrical in shape.  
2. There is only one layer of SMCs on the vessel. 
3. The SMCs have only two end points. 
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4. There are two visible types of cells: “wrap” cells, which extend 
across the entire visible portion of the vessel, and “taper” cells, 
which partially extend the visible portion of the vessel (Figure 7). 
 
 
Figure 7:  Confocal microscopy view of SMCs. 1) Wrap cell extends across 
entire visible portion of the artery. 2) Taper cell partially extends across 
visible portion of the artery (40x). 
 
 
Average smooth muscle cell length was calculated based on a formula used in 
previous studies [18, 19], which uses statistical patterns of smooth muscle cell 
orientation to calculate average smooth muscle cell lengths using a single view of an 
image. 
For each 3-D reconstruction, a 100μm length of artery was delineated for 
measurement. Average smooth muscle cell length for each vessel was determined 
using the following equation [18, 19]:  
 
  4	
  
/          
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where Lc is average SMC length; Rv is the radius of the artery; F is the fraction of the 
vessel circumference that measurements were made; Sw is the number of wrap 
cells; St is the length of all tapered cells combined and divided by the length of a 
single wrap cell; and Tv is the number of taper cells.  
Statistical Analysis 
 
Differences in the profunda femoris artery at rest and maximum dilation as well as 
differences in SMC overlap and length between the ligated and control limbs were 
determined using a student t-test. A p-value of less than 0.05 determined statistical 
significance. Data are presented as bar graphs for visual comparison.  
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RESULTS 
The goal of this study was to test the hypothesis that smooth muscle cell, 
SMC, mechanoadaptation occurs during outward remodeling of the collateral stem 
following an upstream occlusion. The first objective was to measure the profunda 
femoris artery diameter in vivo to confirm that the vessel outwardly remodeled and 
exhibited impaired vasodilation at day-7 following occlusion.  
Diameter 
As expected based on previous work, both resting and maximally dilated 
diameters were greater in the profunda femoris artery from the ligated hindlimb 
than the control hindlimb, 72.7 ± 4.3μm vs. 51.2 ± 3.1μm, respectively (p<0.05, 
Figure 8) for resting diameter, and 121.6 ± 2.6μm vs. 109.1 ± 3.4μm, respectively 
(p<0.05, Figure 8) for maximally dilated diameter. Also as predicted, the percent 
change in diameter from resting to maximum dilation was greater in the profunda 
femoris artery from control hindlimb than the ligated hindlimb, 117.1 ± 14.1% vs. 
69.3 ± 7.6%, respectively (p<0.05, Figure 8). 
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Figure 8:  Profunda Femoris Diameter. A) Image of profunda femoris at resting 
diameter. B) Image of profunda femoris at maximally dilated diameter. C) Vessel 
diameter before and after dilation on control and ligated limbs. D) Percent change in 
vessel diameter from resting to maximum dilation, n=6; *p<0.05. 
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SMC Overlap and Length - Mechanoadaptation 
 Mechanoadaptation is expected to occur during the outward remodeling 
process because based on previous studies, SMC proliferation does not occur. 
The SMC overlap in the ligated hindlimb was shorter than the SMC overlap in the 
control hindlimb, 43.8 ± 1.4μm vs. 50.5 ± 1.9μm, respectively (p<0.05, Figure 9).  
Smooth muscle length was longer in the ligated hindlimb than in the control limb, 
248.9 ± 13.1μm vs 205 ± 9.6μm, respectively, (p<0.05, Figure 10). 
 
Figure 9: Smooth Muscle Cell Overlap. A) Overlap of two smooth muscle cells 
denoted in blue (40x). B) Average SMC overlap in the profunda femoris artery in the 
control and ligated hindlimbs, n=6; *p<0.05. 
A 
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Figure 10:  Smooth Muscle Cell Length. Average smooth muscle cell length in the 
profunda femoris artery in the ligated and control hindlimbs, n=6; *p<0.05. 
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DISCUSSION 
 
 Patients with PAOD experience intermittent claudication, which may be 
explained by impaired vasodilation, therefore, restoring vasodilation is a potential 
method to alleviate symptoms. In animal models, impaired vasodilation in the stem 
of the collateral network can be attributed to smooth muscle cell dysfunction [16]. It 
has been previously established that smooth muscle cell, SMC, proliferation does not 
occur in the collateral stem and therefore is not the cause of the impaired 
vasodilation. To further investigate the cause of the impaired vasodilation, the goal 
of the study was to test the hypothesis that the vascular smooth muscle cells in the 
collateral stem artery underwent mechanoadaptation, or the reorientation of the 
cells in response to a mechanical stimulus.   
 The first step to test this hypothesis was to reaffirm that outward remodeling 
and impaired vasodilation occurred in the collateral stem following an upstream 
arterial occlusion by measuring the diameters of the profunda femoris artery, the 
collateral stem, in vivo at rest and at maximum dilation. We found that the ligated 
hindlimb exhibited a larger diameter at rest and at maximum dilation than the 
control, suggesting that outward remodeling had occurred. However, the percent 
change in the diameter from rest to maximum dilation was larger in the control 
hindlimb, indicating that vasodilation was impaired in the ischemic hindlimb.  
 Having confirmed that vasodilation was impaired; the second objective was 
to measure the lengths and overlaps of the individual smooth muscle cells in the 
profunda femoris artery to determine whether mechanoadaptation had occurred. It 
was found that SMCs had less overlap in the ligated hindlimb than the control.  It 
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was also found that SMCs had a longer average cell length in the ligated hindlimb. 
These findings suggest that the SMCs of the collateral stem in the ischemic hindlimb 
have undergone mechanoadaptation.   
 The results from this study indicate that there is a correlation between 
impaired vasodilation and SMC mechanoadaptation occurrence in the collateral 
stem artery. We want to further investigate whether mechanoadaptation is both 
sufficient and necessary for vasodilation impairment. One way to determine 
whether it is necessary is to block mechanoadaptation from occurring after femoral 
artery ligation. One possible method for this is to use endothelial nitric oxide 
synthase (eNOS) inhibitors to prevent outward remodeling post-ligation. It is 
believed that eNOS plays a role in collateral remodeling because an increase in fluid 
shear stress activates eNOS and causes vascular smooth muscle relaxation in 
arteries, this is also known as flow-mediated dilation which, when chronic, leads to 
outward remodeling of the vessel [20]. It is of interest to inhibit eNOS and therefore 
block outward remodeling to determine whether vasodilation under these 
conditions exhibits impairment. 
 PAOD patients with pre-existing collaterals have a better prognosis than 
those who do not.  In this study, C57BL/6 mice, which have pre-existing collaterals, 
were studied. A further experiment would be follow the same protocol using Balb/c 
mice, which have fewer pre-existing collaterals and less collateral remodeling [21], 
to see whether similar effects in smooth muscle cell mechanoadaptation are 
observed. This would be a useful study to complete to better understand how 
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different collateral anatomies react to an arterial occlusion because there is 
evidence that collateral density and remodeling varies among humans [21]. 
 When making conclusions and interpretations from this data, it is important 
to consider that there were limitations in this study. In calculating SMC length, it 
was assumed that all vessels were perfectly cylindrical. Although the vessels might 
not be perfectly cylindrical, several actions were taken to address this including 
using perfusion fixation to maintain the cylindrical shape and using depression 
slides to mount the samples to prevent the arteries from being pressed and 
misshapen between the glass. It is believed that these actions aided in reducing the 
variability and error.  
 Further understanding of impaired vasodilation will lead to greater 
understanding of intermittent claudication and PAOD, which affects millions of 
Americans. Investigating smooth muscle cell orientation, which may play a role in 
impaired vasodilation, leads us to gain a better insight of the disease in the hopes of 
creating an effective treatment in the future.  
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 APPENDIX A 
Confocal Images of the Profunda Femoris Artery
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Femoral Ligation Protocol 
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Perfusion Fixation Protocol 
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Confocal Imaging Protocol 
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